[Skip to Navigation]
Special Communication
February 9, 2023

Mpox—A Rapidly Evolving Disease

Author Affiliations
  • 1Dermatology Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland
  • 2Dermatology Service and Research Service, Department of Veterans Affairs, Nashville, Tennessee
  • 3Department of Dermatology, Vanderbilt University Medical Center, Nashville, Tennessee
  • 4Department of Dermatology, George Washington University, Washington, DC
  • 5Department of Dermatology, University of California, San Francisco
JAMA Dermatol. 2023;159(4):424-431. doi:10.1001/jamadermatol.2023.0041
Abstract

The 2022 mpox outbreak has rapidly emerged onto the global medical scene while the world continues to grapple with the COVID-19 pandemic. Unlike COVID-19, however, most patients with mpox present with skin findings, the evolving clinical presentation of which may be mistaken for other common skin diseases, particularly sexually transmitted infections. This Special Communication provides an overview of the evolution of mpox skin findings from its initial description in humans in 1970 to the present-day multinational outbreak.

Add or change institution
×